HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

Abstract
Inflammatory mediators present in the tumor milieu may promote cancer progression and are considered promising targets of novel biological therapies. We previously reported that the marine antitumor agent trabectedin, approved in Europe in 2007 for soft tissue sarcomas and in 2009 for ovarian cancer, was able to downmodulate the production of selected cytokines/chemokines in immune cells. Patients with myxoid liposarcoma (MLS), a subtype characterized by the expression of the oncogenic transcript FUS-CHOP, are highly responsive to trabectedin. The drug had marked antiproliferative effects on MLS cell lines at low nanomolar concentrations. We tested the hypothesis that trabectedin could also affect the inflammatory mediators produced by cancer cells. Here, we show that MLS express several cytokines, chemokines, and growth factors (CCL2, CCL3, CCL5, CXCL8, CXCL12, MIF, VEGF, SPARC) and the inflammatory and matrix-binder protein pentraxin 3 (PTX3), which build up a prominent inflammatory environment. In vitro treatment with noncytotoxic concentrations of trabectedin selectively inhibited the production of CCL2, CXCL8, IL-6, VEGF, and PTX3 by MLS primary tumor cultures and/or cell lines. A xenograft mouse model of human MLS showed marked reduction of CCL2, CXCL8, CD68+ infiltrating macrophages, CD31+ tumor vessels, and partial decrease of PTX3 after trabectedin treatment. Similar findings were observed in a patient tumor sample excised after several cycles of therapy, indicating that the results observed in vitro might have in vivo relevance. In conclusion, trabectedin has dual effects in liposarcoma: in addition to direct growth inhibition, it affects the tumor microenvironment by reducing the production of key inflammatory mediators.
AuthorsGiovanni Germano, Roberta Frapolli, Matteo Simone, Michele Tavecchio, Eugenio Erba, Samantha Pesce, Fabio Pasqualini, Federica Grosso, Roberta Sanfilippo, Paolo G Casali, Alessandro Gronchi, Emanuela Virdis, Eva Tarantino, Silvana Pilotti, Angela Greco, Manuela Nebuloni, Carlos Maria Galmarini, Juan Carlos Tercero, Alberto Mantovani, Maurizio D'Incalci, Paola Allavena
JournalCancer research (Cancer Res) Vol. 70 Issue 6 Pg. 2235-44 (Mar 15 2010) ISSN: 1538-7445 [Electronic] United States
PMID20215499 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Antineoplastic Agents, Alkylating
  • CD68 antigen, human
  • Chemokine CCL2
  • Dioxoles
  • Inflammation Mediators
  • Interleukin-6
  • Interleukin-8
  • Serum Amyloid P-Component
  • Tetrahydroisoquinolines
  • Vascular Endothelial Growth Factor A
  • PTX3 protein
  • C-Reactive Protein
  • Trabectedin
Topics
  • Animals
  • Antigens, CD (biosynthesis, immunology)
  • Antigens, Differentiation, Myelomonocytic (biosynthesis, immunology)
  • Antineoplastic Agents, Alkylating (pharmacology)
  • C-Reactive Protein (biosynthesis)
  • Cell Cycle (drug effects)
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Chemokine CCL2 (biosynthesis)
  • Dioxoles (pharmacology)
  • Humans
  • Immunohistochemistry
  • Inflammation Mediators (immunology, metabolism)
  • Interleukin-6 (biosynthesis)
  • Interleukin-8 (biosynthesis)
  • Liposarcoma, Myxoid (drug therapy, immunology, metabolism, pathology)
  • Macrophages (immunology)
  • Mice
  • Serum Amyloid P-Component (biosynthesis)
  • Tetrahydroisoquinolines (pharmacology)
  • Trabectedin
  • Vascular Endothelial Growth Factor A (biosynthesis)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: